Google gained permission to buy a $12B stake, coinciding with positive late-stage trial results for a cancer vaccine.
1 report, 1 independent
Updated Aug 19
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Google gained permission to buy a $12B stake, coinciding with positive late-stage trial results for a cancer vaccine.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Positive interim readout reported for melanoma trials involving Moderna and Merck.Sub-event
Google is set to acquire a stake while Moderna and Merck report positive cancer vaccine trial results.1 source
Keep exploring
The entities involved
-
Google
American multinational technology company, a subsidiary of Alphabet Inc.
-
Moderna
American biotechnology company
-
Merck
public company in Indonesia
Related events
- Moderna and Merck announced a partnership on their mRNA cancer vaccine trial, leading to analyst rating hikes.
- A market rally was observed in the biotech sector, driven by positive cancer vaccine news, causing Eli Lilly shares to rise.
- Moderna, Merck, and the National Cancer Institute announced successful trial results for a combined cancer vaccine and immunotherapy program.
- Developments include positive clinical results for an mRNA vaccine, a major design partnership between Google and Marvell, and macroeconomic shifts regarding currency and Bitcoin.
- Analyst comments on industry trends regarding Moderna's competition in the cancer vaccine market.